312 posters,  10 topics,  270 authors,  220 institutions

ePostersLive® by SciGen® Technologies S.A. All rights reserved.

158
A New Super Absorbent Silicone Dressing for Use In the Management of Moderate to Highly Exuding Wounds

Primary tabs

Poster Presenter
Authors

Rate

No votes yet

Statistics

190 reads

Mr. Simon Barrett, Lead TVN, Humber NHS Foundation Trust, Mrs Rosie Callaghan, TVN, Worcestershire Health & Care Trust, Dr Paul Chadwick PhD MSc (res) BSc (hons) FCPM, National Clinical Director at the College of Podiatry, Mrs Samantha Haycocks, FFPM RCPS (Glasg), Advanced Podiatrist Salford Royal (NHS) Foundation Trust, Professor Jackie Stephen-Haynes, Professor and Consultant Nurse in Tissue Viability, Birmingham City University and Worcestershire Health & Care Trust.

Aims: This Case Study Series investigates the use of a new superabsorbent wound dressing used for exudate management (in medium to high exuding wounds) in a patient population (n = 50) with a variety of different types of wounds.

Background: Wound exudate is an important component of the wound healing response and has implications in both acute and chronic wound healing (Chamanga, 2015). In acute wounds, wound exudate is at its highest level during the inflammatory phase and contains many components that are beneficial to healing (e.g) (Spear, 2012; Power et al., 2017). In chronic wounds however, wound exudate contains components that are deleterious and compromise the healing response (Serra et al., 2013; Amato et al., 2015; Junka et al., 2017, Amato et al., 2015; Humbert et al., 2017)

Methods: This was a non-comparative Case Study Series evaluation, where both acute and chronic wounds with moderate to high exudate production levels were assessed (over a period of two weeks) as requiring exudate management as part of their normal treatment regimen. Clinicians recorded a subjective assessment of exudate management and its impact on peri-wound skin conditions. In addition wound bed preparation, healing trajectory and pain level reduction were monitored to give an insight into the clinical implications of using this dressing. Data was also collected from clinicians and patients to provide information on clinical performance of the dressing.

A sub population analysis on the 10 patients identified on an ad hoc basis was undertaken in order to identify and compare the costs of treatment before and during use with Zetuvit Plus.  

 

Enter Poster ID (e.gGoNextPreviousCurrent